Laboratory Corp. of America Holdings (NYSE:LH)
An independent clinical laboratory company that offers a range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
MFBriguy
(99.84)
Submitted: 12/9/2011 2:15:39 PM :
Start Price:
$83.68
LH Score:
+0.83
SA Pick - Best Buy Now
Recs
jzd999explosion
(79.20)
Submitted: 11/28/2011 5:36:44 PM :
Start Price:
$83.00
LH Score:
-3.45
M* ultimate stockpickers
Recs
Recs
SugarAddict5
(38.90)
Submitted: 4/15/2011 8:59:18 PM :
Start Price:
$95.02
LH Score:
-8.14
Strong fundamentals, and a growing patient base, should outperform based on industry leading profitability
Recs
BoiseKen
(94.94)
Submitted: 3/3/2011 4:03:40 PM :
Start Price:
$91.05
LH Score:
-1.86
would love to get it on a pull back -- long term out performer in a duopoly market.
Recs
94impala
(< 20)
Submitted: 2/24/2011 4:56:11 PM :
Start Price:
$88.82
LH Score:
-0.83
Low cost leader. Check the population/age curve and watch what happens with healthcare reform. Testing demand will go up and LH is my pick.
Recs
sbfrk
(< 20)
Submitted: 2/8/2011 3:13:19 PM :
Start Price:
$90.76
LH Score:
-2.25
Low Cost leader in the medical industry. Other companies will be hurt if prices come down, but LabCorp has great profit margins.
Recs
DrTechnical
(< 20)
Submitted: 1/25/2011 8:07:01 PM :
Start Price:
$84.85
LH Score:
-6.41
The company is concentrating efforts to develop (or acquire) technology for genetic testing, with its associated higher margins than regular routine blood tests. Coupled with its existing DNA testing facility, plus the recently acquired genetics testing arm of Genzyme, LabCorp is well-positioned for the testing needs of the future. In addition, its efforts to automate the testing process (which is currently very labor-intensive) will help keep costs low to remain competitive.
Recs
suckershelf
(< 20)
Submitted: 1/19/2011 11:30:48 AM :
Start Price:
$89.89
LH Score:
-4.22
Sustained itself in difficult industry/time, potential to rise and undervalued.
Recs
owens4414
(< 20)
Submitted: 1/6/2011 1:53:10 PM :
Start Price:
$89.98
LH Score:
-5.33
Good numbers, growth industry.
Recs
Hornblower1810
(< 20)
Submitted: 1/1/2011 7:32:00 PM :
Start Price:
$88.35
LH Score:
-4.14
As hospitals consolidate they are acquiring primary care practices in their communities. These practices are now directing much of their lab tests to Lab Corp. True, the office & waiting rooms of Lab Corp are far from glamorous but they are highly efficient, fast, reliable and low cost. Plus you can order your own lab testing online with no need for a physician referral if you like.
Recs
lovesstocks2
(74.94)
Submitted: 12/30/2010 11:57:33 AM :
Start Price:
$88.59
LH Score:
-5.32
Great margins and great management
Recs
gtechie
(36.71)
Submitted: 12/27/2010 2:09:42 PM :
Start Price:
$88.09
LH Score:
-4.74
Re-rec from SA... watching this one a bit closer now.
Recs
Recs
DanielSparks
(64.71)
Submitted: 12/18/2010 10:39:32 AM :
Start Price:
$89.45
LH Score:
-7.15
Laboratory Corp has produced steady free cash flow. Its business is easy to understand and extremely predictable--just like its free cash flow. This is an undervalued business with low downside risk and great potential. You can't go wrong buying this business at this price.
Recs
hybridinvestor
(51.01)
Submitted: 4/26/2010 4:13:29 PM :
Start Price:
$78.23
LH Score:
-3.72
Purely technical decision related to overall near-term weakness in the healthcare sector vs. the market. This is a great company I've owned long before and made a nice return that would have been even nicer if I held it longer. Using this near-term pan to help me track my expected pullback in different healthcare issues I like to hopefully be able to get back into them at lower prices.
Recs
mj2boogie
(42.01)
Submitted: 4/24/2010 4:46:03 PM :
Start Price:
$77.88
LH Score:
+3.18
Additional people covered under the new healthcare bill will lead to more spending and increased stock price for LH.
Recs
Recs
huddaman
(96.73)
Submitted: 3/3/2010 12:09:47 PM :
Start Price:
$76.95
LH Score:
-1.03
- cheap valuation
- extremely profitable business
- very little competition
- favorable long term demographics
- quality management
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 64 : 1 2 3 4 Next »